標(biāo)題: Titlebook: Ovarian Cancer; State of the Art and George Coukos,Andrew Berchuck,Robert Ozols Conference proceedings 2008 The Editor(s) (if applicable) a [打印本頁(yè)] 作者: tornado 時(shí)間: 2025-3-21 17:31
書目名稱Ovarian Cancer影響因子(影響力)
書目名稱Ovarian Cancer影響因子(影響力)學(xué)科排名
書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度
書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Ovarian Cancer被引頻次
書目名稱Ovarian Cancer被引頻次學(xué)科排名
書目名稱Ovarian Cancer年度引用
書目名稱Ovarian Cancer年度引用學(xué)科排名
書目名稱Ovarian Cancer讀者反饋
書目名稱Ovarian Cancer讀者反饋學(xué)科排名
作者: 流逝 時(shí)間: 2025-3-21 22:10
Karen M. Hajra,Lijun Tan,J. Rebecca Liue book focusing on the understanding of Fluorescein angiogra.Fluorescein angiography is an indispensable tool in modern ophthalmology. It is founded on the evaluation of phenomena related to the behavior intravenously administered sodium fluorescein in the tissues of the ocular fundus..Commonly, tex作者: jeopardize 時(shí)間: 2025-3-22 04:28 作者: Bone-Scan 時(shí)間: 2025-3-22 05:09
Fabian Benencia,George Coukose book focusing on the understanding of Fluorescein angiogra.Fluorescein angiography is an indispensable tool in modern ophthalmology. It is founded on the evaluation of phenomena related to the behavior intravenously administered sodium fluorescein in the tissues of the ocular fundus..Commonly, tex作者: 連鎖,連串 時(shí)間: 2025-3-22 09:23 作者: 爭(zhēng)論 時(shí)間: 2025-3-22 15:40
Potential and Limitations in Early Diagnosis of Ovarian Cancer spread outside the ovaries, and about 90% when disease is confined to the ovaries. Ten-year survival for ovarian carcinoma varies greatly according to the stage at diagnosis (1) and survival is best when cancer is confined to the ovary at the time of diagnosis (Fig. 1); even patients with high-grad作者: Prophylaxis 時(shí)間: 2025-3-22 19:27 作者: PHIL 時(shí)間: 2025-3-22 21:30
Classification of Ovarian Cancer: A Genomic Analysis due to the lack of reliable screening tools, the late stage of disease at the time of diagnosis, the high rate of recurrence of the disease, and the poor response to chemotherapy in the recurrent setting. Patients who present with stage I disease have over 90% 5-year survival, while those diagnosed作者: BOAST 時(shí)間: 2025-3-23 02:55
Epigenetic Markers of Ovarian Cancerr is often asymptomatic in its early stages and because of lack of early detection strategies, most patients are diagnosed with disseminated disease, for whom the 5-year overall survival rate is only 20% (2). In the absence of an early detection test, improved therapies for advanced disease are crit作者: TIGER 時(shí)間: 2025-3-23 07:48 作者: conformity 時(shí)間: 2025-3-23 10:38
MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatmentein-coding genes, and our knowledge on alterations of the functional noncoding sequences in cancer is largely absent. MicroRNAs (miRNAs) are ~22 nucleotide (nt) noncoding RNAs, which regulate gene expression in a sequence-specific manner via translational inhibition or mRNA degradation. Mounting evi作者: flaunt 時(shí)間: 2025-3-23 14:28 作者: 使習(xí)慣于 時(shí)間: 2025-3-23 18:15 作者: Disk199 時(shí)間: 2025-3-23 23:26 作者: Focus-Words 時(shí)間: 2025-3-24 03:05 作者: 食料 時(shí)間: 2025-3-24 07:48 作者: CBC471 時(shí)間: 2025-3-24 14:39 作者: thwart 時(shí)間: 2025-3-24 16:47 作者: 強(qiáng)有力 時(shí)間: 2025-3-24 20:29 作者: nepotism 時(shí)間: 2025-3-25 02:53
Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting thcancers such as childhood leukemias, we have made remarkable progress to the point where survival is an expectation rather than a rarity. Although we do not have one panacea for all human cancers, 30 years later, we understand that each type of cancer and potentially each person’s cancer is differen作者: sebaceous-gland 時(shí)間: 2025-3-25 06:17
Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer of ovarian cancer will be diagnosed, with the majority of these being advanced disease (stage III or stage IV). Survival varies by age, with overall 1-year and 5-year survival rates for new ovarian cancer patients of 76% and 45%, respectively (1). Survival rates drop dramatically with increasing st作者: violate 時(shí)間: 2025-3-25 10:31
Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapyel plus a platinum-based therapy (cisplatin or carboplatin). Although ～80% of patients receiving this therapeutic regimen have an initial favorable response, recurrent disease will occur in a majority of cases. Regrettably, there are currently no effective therapies for those patients with advanced-作者: Confidential 時(shí)間: 2025-3-25 15:27
Biological Therapy with Oncolytic Herpesvirustrains have been genetically engineered, which replicate selectively within tumor cells. Examples include replication-competent mutants of herpes virus, adenovirus, vesicular stomatitis virus, reovirus, and measles virus (2, 17, 37, Martuza, 2000; 56, 63). In particular, replication-competent recomb作者: mighty 時(shí)間: 2025-3-25 16:43 作者: 糾纏,纏繞 時(shí)間: 2025-3-25 23:15 作者: SOBER 時(shí)間: 2025-3-26 01:03
Biological Therapy with Oncolytic Herpesvirusions less likely; (c) antiherpetic drugs are commercially available, which may be used clinically to control undesired side effects, should local or systemic spread of the virus occur; and (d) because of its large genome, HSV offers ample packaging opportunities – up to 30 kb – without affecting viral replication in cancer cells.作者: 過(guò)時(shí) 時(shí)間: 2025-3-26 06:53 作者: 著名 時(shí)間: 2025-3-26 12:23 作者: 載貨清單 時(shí)間: 2025-3-26 14:49 作者: podiatrist 時(shí)間: 2025-3-26 16:51
MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatmentdence shows that miRNAs may play an important role in tumor development, and a better understanding of their alteration in cancer genome and oncogenic property should contribute to the diagnosis and treatment of cancer.作者: 敵手 時(shí)間: 2025-3-27 00:04
Epigenetic Markers of Ovarian Cancer; however, although the majority of patients are initially responsive to chemotherapy, most of them eventually develop drug-resistant disease, that is essentially incurable. A better understanding of the molecular pathogenesis underlying ovarian cancer is the key to identifying markers for early detection and novel therapeutics.作者: Palpable 時(shí)間: 2025-3-27 04:09 作者: 小隔間 時(shí)間: 2025-3-27 06:17 作者: 乳白光 時(shí)間: 2025-3-27 12:13
Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting thll need to become individualized. Specifically targeted drugs continue to receive FDA approval and guide treatment selection on the basis of the underlying dysfunctional genetic, transcriptional, or protein regulation driving their tumor progression.作者: TERRA 時(shí)間: 2025-3-27 13:38 作者: tenosynovitis 時(shí)間: 2025-3-27 18:59 作者: 榮幸 時(shí)間: 2025-3-27 23:57
George Coukos,Andrew Berchuck,Robert OzolsMeeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances i作者: ABOUT 時(shí)間: 2025-3-28 04:48 作者: AV-node 時(shí)間: 2025-3-28 07:44
https://doi.org/10.1007/978-0-387-68969-2B7 family members; BRCA; Carcinom; Epigenetic markers; Ovarian Cancer; Ovulatory factor; Pathogenesis; Regu作者: elastic 時(shí)間: 2025-3-28 10:44
Mandi M. Murph,Debra L. Smith,Bryan Hennessy,Yiling Lu,Corwin Joy,Kevin R. Coombes,Gordon B. Millsormation toward understanding the nature and mechanism of the underlying disorders..The book represents a unique mixture of textbook and atlas, always combining concise statements in English, German, and Spanish on one page with didactically conceived explanatory illustrations on the facing page. ..978-3-642-44085-4978-3-540-30061-8作者: Amnesty 時(shí)間: 2025-3-28 15:59 作者: 娘娘腔 時(shí)間: 2025-3-28 19:41 作者: 巧思 時(shí)間: 2025-3-29 02:22
Fabian Benencia,George Coukosormation toward understanding the nature and mechanism of the underlying disorders..The book represents a unique mixture of textbook and atlas, always combining concise statements in English, German, and Spanish on one page with didactically conceived explanatory illustrations on the facing page. ..978-3-642-44085-4978-3-540-30061-8作者: Obsequious 時(shí)間: 2025-3-29 04:47 作者: RALES 時(shí)間: 2025-3-29 07:33
0065-2598 and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities. .978-1-4419-2396-7978-0-387-68969-2Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 鈍劍 時(shí)間: 2025-3-29 14:27 作者: 為敵 時(shí)間: 2025-3-29 17:28
Caroline A. Barton,Susan J. Clark,Neville F. Hacker,Philippa M. O’Brien作者: 表狀態(tài) 時(shí)間: 2025-3-29 23:19 作者: 沒花的是打擾 時(shí)間: 2025-3-30 02:02
Jurgen M. J. Piek,Paul J. van Diest,René H. M. Verheijen作者: 供過(guò)于求 時(shí)間: 2025-3-30 04:10
David C. Corney,Andrea Flesken-Nikitin,Jinhyang Choi,Alexander Yu. Nikitin作者: fibula 時(shí)間: 2025-3-30 11:41 作者: 相符 時(shí)間: 2025-3-30 14:40
Potential and Limitations in Early Diagnosis of Ovarian Cancerhe last decade (2, 3). However, using these markers to detect ovarian cancer early enough to reduce mortality remains challenging because screening needs to identify cancer before symptoms occur, early enough that the disease is still curable. It is well established that the best screening tests det作者: idiopathic 時(shí)間: 2025-3-30 19:56 作者: artifice 時(shí)間: 2025-3-30 21:05
Classification of Ovarian Cancer: A Genomic Analysishese histotypes resemble various müllerian cell types, with serous tumors resembling Fallopian tube, endometrioid tumors resembling uterine endometrium, mucinous tumors resembling the endocervix, and clear cell tumors resembling endometrial glands during pregnancy (2). Tumors are graded from 1 to 3,作者: 阻撓 時(shí)間: 2025-3-31 03:02 作者: 香料 時(shí)間: 2025-3-31 07:13 作者: strain 時(shí)間: 2025-3-31 12:17 作者: PAEAN 時(shí)間: 2025-3-31 13:47 作者: Goblet-Cells 時(shí)間: 2025-3-31 18:06
Intraperitoneal Chemotherapy for Ovarian Cancerhe peritoneal cavity for much of its natural history, this approach seemed rational. Despite encouraging early results, the IP approach has not been incorporated into the mainstream management of advanced ovarian cancer.作者: aquatic 時(shí)間: 2025-3-31 23:25
Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer the mechanisms that underlie chemoresistance is central to improving patient outcomes for ovarian cancer..The standard adjuvant therapy for ovarian cancer at this time is combination chemotherapy with a platinum-based drug and paclitaxel. The underlying principle of cancer therapy is the selective 作者: ARK 時(shí)間: 2025-4-1 03:31
Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy the tumors. In addition, this delivery route protects healthy organs outside the cavity from harmful side effects. In theory, the ability to target the delivery of DNA to tumor cells, as well as the ability to control its expression once inside the cell, provides an added level of therapeutic effic作者: 轉(zhuǎn)折點(diǎn) 時(shí)間: 2025-4-1 08:18 作者: 演講 時(shí)間: 2025-4-1 11:02
